We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+3.92%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$392M
AUM Growth
+$13.4M
Cap. Flow
+$1.77M
Cap. Flow %
0.45%
Top 10 Hldgs %
64.87%
Holding
28
New
2
Increased
13
Reduced
8
Closed
4

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$28.8M
2
ACH
Accendra Health
ACH
+$7.89M
3
BAX icon
Baxter International
BAX
+$4.95M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.81M
5
MDCO
Medicines Co
MDCO
+$3.46M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$15.7M
2
DGX icon
Quest Diagnostics
DGX
+$8.81M
3
LPNT
LifePoint Health, Inc.
LPNT
+$8.79M
4
LLY icon
Eli Lilly
LLY
+$7.03M
5
BSX icon
Boston Scientific
BSX
+$6.32M

Sector Composition

Rank Sector Weight
1 Healthcare 89.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
1
Baxter International
BAX
$11.7B
$49.9M 12.74%
1,313,554
+132,552
+11% +$4.95M
LLY icon
2
Eli Lilly
LLY
$1.05T
$31.2M 7.98%
374,247
-92,200
-20% -$7.03M
BSX icon
3
Boston Scientific
BSX
$65.4B
$31.2M 7.97%
1,764,000
-353,600
-17% -$6.32M
JNJ icon
4
Johnson & Johnson
JNJ
$609B
$28M 7.16%
+287,800
New +$28.8M
SYK icon
5
Stryker
SYK
$123B
$25M 6.38%
261,483
+12,600
+5% +$1.19M
RVTY icon
6
Revvity
RVTY
$12.3B
$18.7M 4.77%
355,060
-65,200
-16% -$3.4M
BMY icon
7
Bristol-Myers Squibb
BMY
$124B
$18.6M 4.75%
279,400
+3,500
+1% +$231K
CAH icon
8
Cardinal Health
CAH
$53.5B
$17.5M 4.47%
209,400
+9,600
+5% +$848K
THC icon
9
Tenet Healthcare
THC
$16.8B
$17M 4.33%
293,000
+31,500
+12% +$1.61M
IRWD icon
10
Ironwood Pharmaceuticals
IRWD
$635M
$16.9M 4.32%
1,675,052
+287,396
+21% +$3.34M
BIO icon
11
Bio-Rad Laboratories Class A
BIO
$8.15B
$15.9M 4.05%
105,400
+13,000
+14% +$1.86M
TEVA icon
12
Teva Pharmaceuticals
TEVA
$37.3B
$15.5M 3.95%
262,000
+78,000
+42% +$4.81M
MDCO
13
DELISTED
Medicines Co
MDCO
$12.9M 3.29%
450,750
+124,100
+38% +$3.46M
IART icon
14
Integra LifeSciences
IART
$1.5B
$12.7M 3.25%
462,537
+10,030
+2% +$267K
CI icon
15
Cigna
CI
$74.5B
$11.8M 3.02%
73,000
-22,200
-23% -$3.07M
MASI
16
DELISTED
Masimo
MASI
$10.6M 2.7%
272,623
+8,200
+3% +$294K
THOR
17
DELISTED
THORATEC CORPORATION
THOR
$10.2M 2.61%
229,300
-20,200
-8% -$884K
CYH icon
18
Community Health Systems
CYH
$465M
$10.1M 2.57%
193,479
+55,781
+41% +$2.5M
VRTX icon
19
Vertex Pharmaceuticals
VRTX
$123B
$9.07M 2.32%
73,463
-1,000
-1% -$126K
RAD
20
DELISTED
Rite Aid Corporation
RAD
$8.87M 2.27%
53,140
+14,340
+37% +$2.41M
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
$8.35M 2.13%
98,445
-32,100
-25% -$2.71M
ACH
22
Accendra Health
ACH
$266M
$7.96M 2.03%
+234,252
New +$7.89M
MNTA
23
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.2M 0.82%
140,440
-34,660
-20% -$690K
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$475K 0.12%
69,500
– –
COR icon
25
Cencora
COR
$59.9B
– –
-45,300
Closed -$5.15M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2015 Portfolio in Review

As of Q2 2015, Sector Gamma AS held 28 positions worth $392M, up 3.6% from $378M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sector Gamma AS's Q2 2015 filing shows 2 new, 13 increased, 8 reduced and 4 closed positions. Its largest new stake was Johnson & Johnson: 287,800 shares worth $28M. The largest sale was Edwards Lifesciences, an estimated $15.7M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 90% a quarter earlier.

  • Sector Gamma AS's largest Q2 2015 buy was Johnson & Johnson: 287,800 shares worth $28M.
  • Sector Gamma AS added most to Baxter International in Q2 2015, an estimated $4.95M increase.
  • Sector Gamma AS's biggest Q2 2015 reduction was Eli Lilly, cutting an estimated $7.03M.
  • Sector Gamma AS fully exited Edwards Lifesciences in Q2 2015, selling an estimated $15.7M.
  • Sector Gamma AS's ten largest holdings make up 65% of its $392M portfolio in Q2 2015.
  • Sector Gamma AS opened 2 new positions and closed 4 in Q2 2015.
  • Sector Gamma AS's portfolio value rose 3.6% quarter-over-quarter to $392M.

Based on Sector Gamma AS's 13F filing for Q2 2015, filed 13 Aug 2015.